Differential algorithms-assisted molecular modeling-based identification of mechanistic binding of ganoderic acids

Medicinal Chemistry Research

Volumn 24, Issue 9, 2015, Pages 3483-3493

  Gill, Balraj Singh ^a   Kumar, Sanjeev ^a  

^a CENTRAL UNIVERSITY OF PUNJAB   (India)

Author keywords

Ganoderic acids; Molecular studies; NEMO IKK domain

Indexed keywords

ANTINEOPLASTIC AGENT; GANODERIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRITERPENOID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL PROLIFERATION; CHEMICAL BINDING; CRYSTAL STRUCTURE; DISEASE ASSOCIATION; GENETIC ALGORITHM; HYDROGEN BOND; MOLECULAR MODEL; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 84937973345     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-015-1405-x     Document Type: Article

References (18)

1. Agou F, Ye F, Goffinont S, Courtois G, Yamaoka S, Israël A, Véron M (2002) NEMO trimerizes through its coiled-coil C-terminal domain. J Biol Chem 277:17464-17475
2. Allgayer H (2010) Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol/Hematol 73:185-191
3. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Iglehart JD (2004) NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101:10137-10142
4. Chen N-H, Liu J-W, Zhong J-J (2010) Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression. Pharmacol Rep 62:150
5. Daschner PJ, Ciolino HP, Plouzek CA, Yeh GC (1999) Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Breast Cancer Res Treat 53:229-240
6. Dolcet X, Llobet D, Pallares J, Matias-Guiu X (2005) NF-kB in development and progression of human cancer. Virchows Arch 446:475-482
7. Fasshauer D, Sutton RB, Brunger AT, Jahn R (1998) Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q-and R-SNAREs. Proc Natl Acad Sci 95:15781-15786
8. Ghosh S, Karin M (2002) Missing pieces in the NF-κB puzzle. Cell 109:S81-S96
9. Giuliani C, Napolitano G, Bucci I, Montani V, Monaco F (2001) Nf-kB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications]. La Clin Terapeutica 152:249
10. Grover A, Shandilya A, Punetha A, Bisaria VS, Sundar D (2010) Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A. BMC Genom 11:S25
11. Jiang J, Grieb B, Thyagarajan A, Sliva D (2008) Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling. Int J Mol Med 21:577-584
12. Marienfeld RB, Palkowitsch L, Ghosh S (2006) Dimerization of the IκB kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-κB activity. Mol Cell Biol 26:9209-9219
13. May MJ, Marienfeld RB, Ghosh S (2002) Characterization of the IκB-kinase NEMO binding domain. J Biol Chem 277:45992-46000
14. Rushe M, Silvian L, Bixler S, Chen LL, Cheung A, Bowes S, Cuervo H, Berkowitz S, Zheng T, Guckian K (2008) Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure 16:798-808
15. Schomer-Miller B, Higashimoto T, Lee Y-K, Zandi E (2006) Regulation of IκB kinase (IKK) complex by IKKγ-dependent phosphorylation of the T-loop and C terminus of IKKβ. J Biol Chem 281:15268-15276
16. Sliva D (2004) Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr Cancer Drug Targets 4:327-336
17. Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, Schneider RJ, Martínez-Montemayor MM (2013) Anti-tumor effects of ganoderma lucidum (Reishi) in inflammatory breast cancer in vivo and in vitro models. PLoS ONE 8:e57431
18. Tak PP, Firestein GS (2001) NF-κB: a key role in inflammatory diseases. J Clin Invest 107:7-11